Bernd L. Groner

Paul Ehrlich Str. 42
Frankfurt Am Main, HE 60596, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Correction: Weber et al. Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells. Cancers 2015, 7, 503-537.

Correction: Weber et al. Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells. Cancers 2015, 7, 503-537.

Journal: Cancers

Published: April 16, 2025

The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells.

The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells.

Journal: Archives of toxicology

Published: January 19, 2018

Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.

Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.

Journal: Molecular and cellular endocrinology

Published: May 27, 2017

Breast Cancer Patients Have Greatly Benefited from the Progress in Molecular Oncology.

Breast Cancer Patients Have Greatly Benefited from the Progress in Molecular Oncology.

Journal: PLoS biology

Published: September 30, 2016

Tumor cell resistance against targeted therapeutics: the density of cultured glioma tumor cells enhances Stat3 activity and offers protection against the tyrosine kinase inhibitor canertinib.

Tumor cell resistance against targeted therapeutics: the density of cultured glioma tumor cells enhances Stat3 activity and offers protection against the tyrosine kinase inhibitor canertinib.

Journal: MedChemComm

Published: August 13, 2016

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.

Journal: Leukemia

Published: July 06, 2016

Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.

Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.

Journal: Cancer research

Published: August 05, 2015

Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes.

Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes.

Journal: International journal of cancer

Published: April 13, 2015

5-Lipoxygenase is a direct p53 target gene in humans.

5-Lipoxygenase is a direct p53 target gene in humans.

Journal: Biochimica et biophysica acta

Published: March 02, 2015

Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells.

Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells.

Journal: Cancers

Published: December 16, 2014

Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.

Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 16, 2014

Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells.

Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells.

Journal: Frontiers in oncology

Published: July 21, 2014

Showing 1-12 of 41

Last Updated: 09/26/2026